Larry A Harshyne Jr

Larry A. Harshyne, PhD

Contact Dr. Harshyne

1020 Locust Street
Jefferson Alumni Hall
Suite 454
Philadelphia, PA 19107

(215) 503-9893

Most Recent Peer-reviewed Publications

  1. Immune biomarkers of treatment failure for a patient on a phase i clinical trial of pembrolizumab plus radiotherapy
  2. Serum exosomes and cytokines promote a T-helper cell type 2 environment in the peripheral blood of glioblastoma patients
  3. Enhancement of glioma-specific immunity in mice by “NOBEL”, an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide
  4. Glioblastoma exosomes and IGF-1R/AS-ODN are immunogenic stimuli in a translational research immunotherapy paradigm
  5. The somatic genomic landscape of glioblastoma
  6. Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers
  7. c-Jun NH2-terminal kinase 2α2 promotes the tumorigenicity of human glioblastoma cells
  8. Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells
  9. Novel Training Concepts and Techniques Used to Increase Safety Awareness in the Laboratory Animal Facility
  10. A role for class A scavenger receptor in dendritic cell nibbling from live cells
  11. Changes in dendritic cell migration and activation during SIV infection suggest a role in initial viral spread and eventual immunosuppression
  12. Erratum: Dendritic cells acquire antigens from live cells for cross-presentation to CTL. (The Journal of Immunology (2001) 166 (3717-3723))
  13. Dendritic cells acquire antigens from live cells for cross-presentation to CTL
  14. Maturation and trafficking of monocyte-derived dendritic cells in monkeys: Implications for dendritic cell-based vaccines